3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
February 25th, 2022
2.3K views
The present protocol optimizes the liver in situ perfusion/decellularization and two-photon microscopy methods to establish a reliable platform to visualize the dynamics of extracellular matrix (ECM) remodeling during non-alcoholic steatohepatitis (NASH).
Overview
This protocol optimizes liver in situ perfusion/decellularization and two-photon microscopy methods to visualize extracellular matrix (ECM) remodeling during non-alcoholic steatohepatitis (NASH). Understanding ECM dynamics is crucial for insights into liver fibrosis.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Liver Disease Research
Background
- NASH is a significant chronic liver disease globally.
- It can progress to fibrosis, cirrhosis, and liver cancer.
- Traditional imaging methods fail to capture 3D ECM structure changes.
- Understanding ECM dynamics is essential for studying liver fibrosis.
Purpose of Study
- To optimize methods for visualizing ECM remodeling in NASH.
- To enhance understanding of the fibrosis process.
- To establish a reliable platform for future research.
Methods Used
- Liver in situ perfusion/decellularization.
- Two-photon microscopy for imaging.
- Mouse model for studying NASH.
- Preparation and disinfection of the mouse prior to procedures.
Main Results
- Successful visualization of ECM remodeling dynamics.
- Enhanced understanding of the relationship between ECM and liver fibrosis.
- Establishment of a reliable imaging platform.
- Insights into the progression of NASH.
Conclusions
- The optimized methods provide valuable insights into ECM dynamics.
- This research could inform future studies on liver diseases.
- Understanding ECM remodeling is critical for addressing liver fibrosis.
Frequently Asked Questions
What is NASH?
NASH stands for non-alcoholic steatohepatitis, a chronic liver disease that can lead to serious complications.
Why is ECM remodeling important in liver diseases?
ECM remodeling is crucial as it plays a significant role in the progression of liver fibrosis and other liver diseases.
What methods are used to study ECM dynamics?
The study uses liver in situ perfusion/decellularization and two-photon microscopy to visualize ECM changes.
How does this research contribute to understanding liver fibrosis?
By visualizing ECM remodeling, this research provides insights into the mechanisms underlying liver fibrosis.
What are the implications of this study for future research?
The findings could inform future studies on liver diseases and potential therapeutic approaches.
Executive Industry Relevance
Three-dimensional imaging of the liver extracellular matrix (ECM) in NASH models addresses a critical gap in understanding fibrosis progression and ECM remodeling. This capability enhances predictive confidence in preclinical liver disease models and informs target validation for antifibrotic drug discovery. Integrating advanced ECM visualization supports risk-adjusted portfolio decisions at the discovery-to-preclinical inflection point.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct visualization of ECM remodeling to clarify fibrogenic pathways in NASH.
- Supports mechanistic de-risking by distinguishing structural ECM changes between healthy and diseased states.
- Improves predictive confidence for target engagement and biological relevance in fibrosis models.
Screening & Assay Development
- Facilitates preparation of decellularized liver scaffolds for quantitative imaging assays.
- Enables reproducible assessment of ECM architecture for compound screening.
- Provides standardized 3D imaging outputs to benchmark assay performance and scalability.
Translational & Preclinical Research
- Aligns ECM imaging outputs with disease-relevant endpoints in NASH progression.
- Supports continuity from discovery through preclinical validation by enabling direct comparison of ECM remodeling across models.
- Informs translational biomarker development by correlating 3D ECM features with histopathological outcomes.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum by enabling high-resolution ECM analysis in mouse NASH models, supporting both target validation and translational research workflows.
- Discovery Biology: Provides quantitative 3D ECM data to test fibrogenic hypotheses and clarify remodeling mechanisms.
- Screening: Delivers reproducible imaging outputs for evaluating antifibrotic interventions in validated models.
- Analytics: Generates quantitative readouts of ECM structure, supporting statistical comparison of experimental groups.
- Translational Research: Bridges preclinical findings with clinical fibrosis endpoints through advanced ECM characterization.
- Enterprise Reuse: Establishes a reusable imaging platform for diverse liver disease and fibrosis studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in liver fibrosis research.
- Operational Value: Standardizes ECM imaging and analysis for reproducibility and scalability across studies.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient advancement of antifibrotic programs.
- Portfolio Impact: Supports risk-adjusted prioritization of liver disease assets based on robust ECM remodeling data.
Implementation Considerations
- Requires expertise in in situ perfusion, decellularization, and advanced microscopy.
- Demands access to two-photon microscopy and image analysis infrastructure.
- Necessitates cross-team standardization of imaging protocols and data interpretation.
- Adaptation may be needed for different liver disease models or species.
- Careful perfusion technique is critical to avoid artifacts and ensure data quality.
Biopharma FAQs
Why does null hypothesis testing matter for ECM remodeling analysis?
Null hypothesis testing enables objective evaluation of whether observed 3D ECM differences between control and NASH models are statistically significant, supporting robust target validation and reducing false positives in fibrosis research.
How does independent variable isolation fit the decellularization workflow?
Isolating variables such as diet type and perfusion conditions ensures that ECM remodeling outcomes reflect true biological effects, enabling clear attribution of structural changes to experimental interventions in the discovery pipeline.
What do quantitative dependent variable measurements enable in ECM imaging?
Quantitative measurements of ECM features, such as collagen network organization, provide reproducible endpoints for comparing disease progression and therapeutic impact, supporting data-driven decision-making in preclinical studies.
Why are replication requirements critical for cross-functional ECM imaging studies?
Replication ensures that ECM remodeling findings are consistent and reproducible across experiments and teams, facilitating cross-functional collaboration and increasing confidence in translational relevance.
What statistical analysis capabilities are required before ECM imaging implementation?
Robust statistical tools are needed to analyze 3D ECM data, compare experimental groups, and validate significance thresholds, ensuring that imaging outputs support actionable R&D decisions.
Chapters in this video
0:04
Introduction
0:46
Surgical Preparation and Procedures of Liver Perfusion
2:08
Tissue Decellularization and Slide Preparation for Imaging
3:35
Image Acquisition
4:58
Results: Two-Photon Microscopy of the Liver Extracellular Matrix in a Mouse
6:19
Conclusion
